Published in Cancer Res on July 01, 1981
Malignant fibrous histiocytoma. Expression of monocyte/macrophage differentiation antigens detected with monoclonal antibodies. Am J Pathol (1986) 1.06
Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia. Am J Pathol (1982) 0.82
Origin and relationship between different cell types in malignant fibrous histiocytoma. Am J Pathol (1989) 0.78
Integrated control of proliferation and differentiation of mesenchymal stem cells. Environ Health Perspect (1989) 0.77
Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1972) 3.27
Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res (1986) 2.83
The structure of erythrocyte membranes studied by freeze-etching. II. Localization of receptors for phytohemagglutinin and influenza virus to the intramembranous particles. J Exp Med (1972) 2.78
The socio-economic impact of telehealth: a systematic review. J Telemed Telecare (2003) 1.93
Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD. Proc Natl Acad Sci U S A (1982) 1.90
Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol (1984) 1.81
Plasma membrane vesiculation: a new technique for isolation of plasma membranes. Science (1976) 1.73
Plasma membrane vesiculation in 3T3 and SV3T3 cells. I. Morphological and biochemical characterization. J Cell Sci (1979) 1.61
Effects of prostaglandins, epinephrine and NaF on human leukocyte, platelet and liver adenyl cyclase. Blood (1970) 1.57
Structural changes in memebranes of synchronized cells demonstrated by freeze-cleavage. Nature (1971) 1.51
Structural changes in membranes of transformed lymphocytes demonstrated by freeze-etching. Cell Immunol (1972) 1.47
New techniques for the in vitro culture of human skin keratinocytes and perspectives on their use for grafting of patients with extensive burns. Mayo Clin Proc (1986) 1.44
Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats. Antimicrob Agents Chemother (1976) 1.32
The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J Neurosci (1994) 1.23
Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation. J Cell Biol (1982) 1.22
Carcinoid tumor of the thymus: a clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc (1980) 1.22
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res (1987) 1.21
Decreased expression of protooncogenes c-fos, c-myc, and c-jun following polyamine depletion in IEC-6 cells. Am J Physiol (1993) 1.16
Coupling of proadipocyte growth arrest and differentiation. I. Induction by heparinized medium containing human plasma. J Cell Biol (1982) 1.15
Evidence that mitogenic lectins induce changes in lymphocyte membrane fluidity. Nature (1974) 1.14
Ultrastructural aspects of neutrophil granulocyte development in humans. Lab Invest (1970) 1.12
Safety belt use, ejection and entrapment. Health Educ Q (1984) 1.07
Plasma membrane vesiculation in 3T3 and SV3T3 cells. II. Factors affecting the process of vesiculation. J Cell Sci (1979) 1.06
Two functionally distinct classes of growth arrest states in human prokeratinocytes that regulate clonogenic potential. J Invest Dermatol (1986) 1.05
Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol (1996) 1.02
Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins. J Cell Biol (1989) 1.02
Biologic mechanisms for the regulation of normal human keratinocyte proliferation and differentiation. Am J Pathol (1988) 1.02
Efficient extraction of RNA from mammalian tissue. Mol Cell Biochem (1983) 1.01
Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential. J Cell Biol (1986) 1.00
Differences in membrane fluidity and structure in contact-inhibited and transformed cells. Proc Natl Acad Sci U S A (1974) 1.00
Changes in membrane structure associated with cell contact. Proc Natl Acad Sci U S A (1973) 1.00
Policy implications associated with the socioeconomic and health system impact of telehealth: a case study from Canada. Telemed J E Health (2004) 0.99
The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. Proc Natl Acad Sci U S A (1997) 0.98
Vasculitis in hairy cell leukemia: review of literature and consideration of possible pathogenic mechanisms. J Rheumatol (1986) 0.96
In the absence of nutrients, pancreatic-biliary secretions in the jejunum do not exert feedback control of human pancreatic or gastric function. J Lab Clin Med (1980) 0.94
Influence of cell cycle and cell movement on the distribution of intramembranous particles in contact-inhibited and transformed cells. Exp Cell Res (1974) 0.93
Manganese and antibiotic biosynthesis. III. The site of manganese control of patulin production in Penicillium urticae. Can J Microbiol (1986) 0.93
Normal and transformed human prokeratinocytes express divergent effects of a tumor promoter on cell cycle-mediated control of proliferation and differentiation. Carcinogenesis (1985) 0.92
Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol (1995) 0.91
PRomotion of smooth surface tumorigenicity by phorbol myristate acetate in Balb/3T3 cells and Balb/3T3 T proadipocytes. J Natl Cancer Inst (1981) 0.91
Fine structural features of eosinophile granulocyte development in human bone marrow. Evidence for granule secretion. J Ultrastruct Res (1970) 0.91
Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1 phase of the cell cycle. J Cell Physiol (1982) 0.91
Transforming growth factor type beta is a specific inhibitor of 3T3 T mesenchymal stem cell differentiation. Exp Cell Res (1986) 0.91
Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation. Int J Cancer (1986) 0.90
Preferentially expressed genes in chronic myelogenous leukemia. Blood (1985) 0.90
Neoplastic transformation and defective control of cell proliferation and differentiation. Cancer Res (1982) 0.90
Mechanisms for the initiation and promotion of carcinogenesis: a review and a new concept. Mayo Clin Proc (1984) 0.90
Stable overexpression of specific segments of the P2P-R protein in human MCF-7 cells promotes camptothecin-induced apoptosis. J Cell Physiol (2003) 0.88
Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line. Cancer Res (1985) 0.88
Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. Exp Hematol (1984) 0.87
Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia. Cancer Res (1986) 0.87
Cell cycle-associated modulation in cAMP-dependent plasma membrane phosphorylation. Exp Cell Res (1981) 0.87
Biological characteristics of primary cultures of human gallbladder epithelial cells. Lab Invest (1992) 0.87
Freeze-fracture electronmicroscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy. Neurology (1981) 0.87
Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res (1991) 0.87
Fetal growth retardation produced by experimental placental insufficiency in the rhesus monkey. I. Body weight, organ size. Biol Neonate (1971) 0.86
Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology (1996) 0.85
Plate-induced tumors of BALB/3T3 cells exhibiting foci of differentiation into pericytes, chondrocytes, and fibroblasts. J Supramol Struct (1980) 0.85
Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol (1998) 0.85
Senescence represses the nuclear localization of the serum response factor and differentiation regulates its nuclear localization with lineage specificity. J Cell Sci (2001) 0.85
An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases. Proc Natl Acad Sci U S A (1985) 0.85
Plasma membrane phospholipid, cholesterol and fatty acyl composition of differentiated and undifferentiated L6 myoblasts. Lipids (1978) 0.84
Biological mechanisms of stem cell carcinogenesis: a concept for multiple phases in the initiation of carcinogenesis and the role of differentiation control defects. Carcinog Compr Surv (1985) 0.84
Expression patterns of murine lysosome-associated membrane protein 2 (Lamp-2) transcripts during morphogenesis. Differentiation (1999) 0.84
Multiplicative interaction between angiotensin II and K concentration in stimulation of aldosterone. Am J Physiol (1984) 0.83
Two subtypes of reversible cell cycle restriction points exist in cultured normal human keratinocyte progenitor cells. Lab Invest (1988) 0.83
Biological mechanisms for the loss of the differentiated phenotype by non-terminally differentiated adipocytes. Exp Cell Res (1984) 0.83
Health needs and eHealth readiness assessment of health care organizations in Kabul and Bamyan, Afghanistan. East Mediterr Health J (2012) 0.83
Role of the clinical laboratory in the diagnosis and management of malignant melanoma. Mayo Clin Proc (1989) 0.83
Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation. Am J Pathol (1986) 0.83
Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells. J Cell Biol (1996) 0.83
Methylation of deoxycytidine in replicating cells treated with ultraviolet radiation and chemical carcinogens. Carcinogenesis (1984) 0.83
Development and characterization of a rapidly proliferating, well-differentiated cell line derived from normal adult human osteoblast-like cells transfected with SV40 large T antigen. J Bone Miner Res (1992) 0.82
Efficient differentiation of proadipocyte stem cells on nonadherent surfaces: evidence for differentiation without DNA synthesis. J Cell Physiol (1983) 0.82
Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia. Am J Pathol (1982) 0.82
Undifferentiated and differentiated L6 myoblast plasma membranes. I: Comparison of the morphology of plasma membrane vesiculation and the factors influencing the vesiculation process. Cell Differ (1978) 0.81
Hypothalamic cellular and molecular mechanisms helping to satisfy axiomatic requirements for reproduction. J Neuroendocrinol (1996) 0.81
Plasma membrane vesiculation: a cellular response to injury. Virchows Arch B Cell Pathol (1978) 0.81
Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation. J Cell Biochem (1987) 0.81
Manganese and antibiotic biosynthesis. I. A specific manganese requirement for patulin production in Penicillium urticae. Can J Microbiol (1986) 0.81
Coordinate induction of I kappa B alpha and NF kappa B genes. Exp Cell Res (1994) 0.81
Stable induction of c-jun mRNA expression in normal human keratinocytes by agents that induce predifferentiation growth arrest. Cell Growth Differ (1992) 0.81
Selective induction of c-jun and jun-B but not c-fos or c-myc during mitogenesis in SV40-transformed cells at the predifferentiation growth arrest state. Cell Growth Differ (1991) 0.81
Independent alterations in cell shape and intramembranous particle topography induced by cytochalasin B and colchicine in normal and transformed cells. Cancer Res (1976) 0.80
Modulation of the distribution of plasma membrane intramembranous particles in contact-inhibited and transformed cells. Biochim Biophys Acta (1975) 0.80
Plasma membrane intramembranous particle topography in 3T3 and SV3T3 cells: the effect of cytochalasin B. J Cell Sci (1977) 0.80
Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation. J Cell Physiol (1988) 0.80
HLA-DR-associated invariant chain is highly expressed in chronic lymphocytic leukemia. Blood (1986) 0.80
Insulin-induced mitogenesis associated with transformation by the SV40 large T antigen. J Cell Physiol (1991) 0.79
Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation. J Cell Physiol (1990) 0.79
Manganese and antibiotic biosynthesis. II. Cellular levels of manganese during the transition to patulin production in Penicillium urticae. Can J Microbiol (1986) 0.79
Induction of replicative DNA synthesis in quiescent human fibroblasts by DNA damaging agents. Proc Natl Acad Sci U S A (1984) 0.79
Cyclic neutropenia in grey collie dogs. Ultrastructural evidence for abnormal neutrophil granulopoiesis. Lab Invest (1973) 0.79
Differential mitogenic effects of methyl isobutyl xanthine and a tumor growth factor on G1-arrested 3T3 T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS state. Exp Cell Res (1983) 0.78
Induction of c-jun independent of PKC, pertussis toxin-sensitive G protein, and polyamines in quiescent SV40-transformed 3T3 T cells. Exp Cell Res (1992) 0.78